Prothena: Q2 Earnings Snapshot
In this article:
DUBLIN (AP) — DUBLIN (AP) — Prothena Corp. (PRTA) on Thursday reported a loss of $54.6 million in its second quarter.
On a per-share basis, the Dublin-based company said it had a loss of $1.03.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.
The drug developer posted revenue of $4 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $10.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA
